Immune Checkpoint Inhibitors in Cancer Therapy

The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized monoclonal antibodies, targeting these immune checkpoint proteins have been utilized successfully in patients with metastatic mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiravand, Yavar, Khodadadi, Faezeh, Kashani, Seyyed Mohammad Amin, Hosseini-Fard, Seyed Reza, Hosseini, Shadi, Sadeghirad, Habib, Ladwa, Rahul, O’Byrne, Ken, Kulasinghe, Arutha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139602/
https://www.ncbi.nlm.nih.gov/pubmed/35621637
http://dx.doi.org/10.3390/curroncol29050247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139602/
https://www.ncbi.nlm.nih.gov/pubmed/35621637
http://dx.doi.org/10.3390/curroncol29050247

Ejemplares similares